
Vaidya Sane Ayurved Laboratories Limited
The current stock price of Vaidya Sane Ayurved Laboratories Limited is ₹91.15, with a target price range between ₹86.59 and ₹95.71. The stock has experienced a price change of ₹1.30 (1.45%), reflecting recent market volatility.
Today's opening price was ₹89.00, while the previous close stood at ₹89.85.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Vaidya Sane Ayurved Laboratories Limited Price Chart
Vaidya Sane Ayurved Laboratories Limited Pre Open Market Overview: N/A
Key Metrics:
- IEP (Indicative Equilibrium Price): 0
- Previous Close Price: 0
- Change: 0.00%
- Total Traded Volume: 0
- Total Buy Quantity: 0
- Total Sell Quantity: 0
Price | Buy Qty | Sell Qty |
---|---|---|
0.00 | 0.00 | 0.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
Bid | Qty | Ask | Qty |
---|---|---|---|
90.10 | 400 | 92.00 | 800 |
89.05 | 400 | 95.50 | 7,200 |
88.60 | 400 | 95.90 | 400 |
88.55 | 21,600 | 96.60 | 400 |
88.05 | 400 | 102.95 | 400 |
Shareholding Patterns of Vaidya Sane Ayurved Laboratories Limited
Key Trade Statistics of Vaidya Sane Ayurved Laboratories Limited
Trade Information | Details |
---|---|
Traded Volume (Lakhs) | 0.25 |
Traded Value (₹ Cr.) | 0.23 |
Total Market Cap (₹ Cr.) | 95.83 |
Free Float Market Cap (₹ Cr.) | 31.17 |
Impact cost | N/A |
Quantity Traded | 25,200.00 |
Deliverable Quantity | 24,000.00 |
% of Quantity to Traded | 95.24 |
Security VaR | N/A |
Index VaR | N/A |
VaR Margin | 50 |
Extreme Loss Rate | 3.5 |
Adhoc Margin | N/A |
Applicable Margin Rate | 53.5 |
Face Value | 10 |
Key Price Statistics of Vaidya Sane Ayurved Laboratories Limited
The 52-week high for Vaidya Sane Ayurved Laboratories Limited was ₹217.80, recorded on 24-Apr-2024. On the other hand, the 52-week low stands at ₹87.30, with the lowest value recorded on 18-Mar-2025.
The upper band for trading is ₹107.80, and the lower band is ₹71.90. The price band is 20%.
The stock's daily volatility stands at N/A, while the annualized volatility is N/A. The tick size for trading is ₹0.05.
Price Information | Details |
---|---|
52 Week High (24-Apr-2024) | 217.80 |
52 Week Low (18-Mar-2025) | 87.30 |
Upper Band | 107.80 |
Lower Band | 71.90 |
Price Band (%) | 20 |
Daily Volatility | - |
Annualised Volatility | - |
Tick Size | 0.05 |
Key Securities Statistics of Vaidya Sane Ayurved Laboratories Limited
Securities Information | Details |
---|---|
Status | Listed |
Trading Status | Active |
Date of Listing | 23-Feb-2022 |
Adjusted P/E | 23.18 |
Symbol P/E | 23.18 |
Index | NIFTY SME EMERGE |
Macro-Economic Sector | Healthcare |
Sector | Healthcare |
Industry | Healthcare Equipment & Supplies |
Basic Industry | Medical Equipment & Supplies |
Security Status of Vaidya Sane Ayurved Laboratories Limited
Title | Details |
---|---|
Board Status | SME |
Trading Segment | Normal Market |
Session No. | - |
Class of Shares | Equity |
SDD Compliance | - |
Name of Compliance Officer | - |
Announcements of Vaidya Sane Ayurved Laboratories Limited
Subject | Date |
---|---|
Analysts/Institutional Investor Meet/Con. Call Updates | 28-Feb-2025 |
Analysts/Institutional Investor Meet/Con. Call Updates | 28-Feb-2025 |
Press Release | 22-Feb-2025 |
Outcome of Board Meeting | 18-Feb-2025 |
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 17-Feb-2025 |
Statement of deviation(s) or variation(s) under Reg. 32 | 13-Feb-2025 |
Outcome of Board Meeting | 13-Feb-2025 |
General Updates | 05-Feb-2025 |
Corporate Actions of Vaidya Sane Ayurved Laboratories Limited
Face Value | Purpose | Ex-Date |
---|---|---|
10 | ANNUAL GENERAL MEETING | 20-Sep-2024 |
10 | ANNUAL GENERAL MEETING/DIVIDEND - RE 0.25 PER SHARE | 05-Sep-2023 |
10 | EXTRA ORDINARY GENERAL MEETING | 27-Jul-2023 |
10 | EXTRA ORDINARY GENERAL MEETING | 13-Apr-2023 |
10 | INTERIM DIVIDEND - RE 0.25 PER SHARE | 18-Nov-2022 |
10 | ANNUAL GENERAL MEETING | 20-Jun-2022 |
Board Meetings of Vaidya Sane Ayurved Laboratories Limited
Financial Results of Vaidya Sane Ayurved Laboratories Limited
Company Directory of Vaidya Sane Ayurved Laboratories Limited
Web Address | Office | Address | City |
---|---|---|---|
- | Registered Address | Fl. 5, 1047, Shriram Bhawan Shukrawar Peth PUNE - 411002 PUNE |
PUNE |
- | Corporate Office | 201 B, Bhoomi Velocity, Road No. 23 Above ICICI Bank, Wagle Estate Thane West THANE (WEST) - 400604 THANE |
THANE (WEST) |
- | Transfer Agent | 1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis, Makwana Road, Marol Andheri East MUMBAI - 400059 MUMBAI |
MUMBAI |
Insider Trading of Vaidya Sane Ayurved Laboratories Limited
Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
---|---|---|---|
7(2) | Denelia Clifford Quadros | 1259100 | Sell |
7(2) | Shripad Ramchandra Upasani | 1692000 | Sell |
7(2) | Suhas Dawkhar | 1120000 | Sell |
7(2) | Suhas Dawkhar | 2156800 | Buy |
7(2) | Gurudatta Amin | 2021242 | Buy |
Annual Reports of Vaidya Sane Ayurved Laboratories Limited
Company | From Year | To Year | Att. |
---|---|---|---|
Vaidya Sane Ayurved Laboratories Limited | 2023 | 2024 | |
Vaidya Sane Ayurved Laboratories Limited | 2022 | 2023 | |
Vaidya Sane Ayurved Laboratories Limited | 2021 | 2022 |
Investor Complaints of Vaidya Sane Ayurved Laboratories Limited
Event Calendar of Vaidya Sane Ayurved Laboratories Limited
Purpose | Details |
---|---|
Board Meeting Intimation | VAIDYA SANE AYURVED LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 11-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Other business. |
Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
VAIDYA SANE AYURVED LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 26-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Other business. | Board Meeting Intimation |
Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2024 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
VAIDYA SANE AYURVED LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2023 to consider Other business. | Board Meeting Intimation |
Other business matters | To consider and approve inter-alia allotment of Share warrants to Non Promoter Group and any other business matter |
VAIDYA SANE AYURVED LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 11-Jul-2023 to consider and approve Fund raising/Other business. | Board Meeting Intimation |
VAIDYA SANE AYURVED LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 11-Jul-2023 to consider and approve Fund raising/Dividend/Other business. | Board Meeting Intimation |
Fund Raising/Other business matters | To consider Fund Raising and other business matters |
Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2023, dividend and other business matters |
Fund Raising/Other business matters | To consider Fund Raising through Share Warrants convertible into Equity Shares through Preferential Allotment to Promoters or Non-promoter and other business matters |
Dividend/Financial results | Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Board Meeting to be held on 10-Nov-2022 to consider Unaudited Standalone and Consolidated financial results for the period ended 30th September 2022 and to consider Interim Dividend. In the event of Interim dividend if declared by the Board, the record date pursuant to Regulations 42 of the SEBI Regulations will be Friday, November 18, 2022, for the purpose of ascertaining the eligibility of the shareholders for payment of Interim Dividend for the FY 2022-23. |
Financial results/Other business matters | Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Board Meeting to be held on 04-May-2022 to consider audited financial statements for the period ended March 2022 and Other business matters |
Share Transfers of Vaidya Sane Ayurved Laboratories Limited
Company | Period | Reg.7 | Reg.40 |
---|---|---|---|
Vaidya Sane Ayurved Laboratories Limited | 31-MAR-2024 | ||
Vaidya Sane Ayurved Laboratories Limited | 31-MAR-2023 |
Voting Results of Vaidya Sane Ayurved Laboratories Limited
Date of Mtg. | Mtg. Type | Resolution |
---|---|---|
30-SEP-2024 | AGM | 1.tTo receive, consider and adopt the Standalone Audited Financial Statements for the year ended 31st March 2024 and report of the Board of Directors and Auditors thereon |
30-SEP-2024 | AGM | 3.tTo appoint a Director in place of Dr. Vidyut Bipin Ghag, who retires by rotation and being eligible, offer herself for reappointment |
30-SEP-2024 | AGM | 2.tTo receive, consider and adopt the Consolidated Audited Financial Statements for the year ended 31st March 2024 and report of the Auditors thereon |
05-AUG-2023 | EGM | To Create, offer, issue and allot convertible warrants on preferential basis to non-promoters of the Company |
24-APR-2023 | EGM | To create, offer, issue and allot Convertible Warrants on Preferential Basis to Promoters & promoter Group of the Company |
29-JUN-2022 | AGM | To Receive, Consider And Adopt The Standalone Audited Financial Statements For The Year Ended 31st March 2022 And Report of The Directors And Auditors Thereon. |
29-JUN-2022 | AGM | To Appoint A Director In Place of Dr. Vidyut Bipin Ghag, Who Retires By Rotation And Being Eligible, Offer Herself For Reappointment |
FAQs on Vaidya Sane Ayurved Laboratories Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.